Your browser doesn't support javascript.
Nationwide Harmonization Effort for Semi-Quantitative Reporting of SARS-CoV-2 PCR Test Results in Belgium.
Cuypers, Lize; Bode, Jannes; Beuselinck, Kurt; Laenen, Lies; Dewaele, Klaas; Janssen, Reile; Capron, Arnaud; Lafort, Yves; Paridaens, Henry; Bearzatto, Bertrand; Cauchie, Mathieu; Huwart, Aline; Degosserie, Jonathan; Fagnart, Olivier; Overmeire, Yarah; Rouffiange, Arlette; Vandecandelaere, Ilse; Deffontaine, Marine; Pilate, Thomas; Yin, Nicolas; Micalessi, Isabel; Roisin, Sandrine; Moons, Veronique; Reynders, Marijke; Steyaert, Sophia; Henin, Coralie; Lazarova, Elena; Obbels, Dagmar; Dufrasne, François E; Pirenne, Hendri; Schepers, Raf; Collin, Anaëlle; Verhasselt, Bruno; Gillet, Laurent; Jonckheere, Stijn; Van Lint, Philippe; Van den Poel, Bea; Van der Beken, Yolien; Stojkovic, Violeta; Garrino, Maria-Grazia; Segers, Hannah; Vos, Kevin; Godefroid, Maaike; Pede, Valerie; Nollet, Friedel; Claes, Vincent; Verschraegen, Inge; Bogaerts, Pierre; Van Gysel, Marjan; Leurs, Judith.
  • Cuypers L; National Reference Centre for Respiratory Pathogens, Department of Laboratory Medicine, University Hospitals Leuven, 3000 Leuven, Belgium.
  • Bode J; National Reference Centre for Respiratory Pathogens, Department of Laboratory Medicine, University Hospitals Leuven, 3000 Leuven, Belgium.
  • Beuselinck K; National Reference Centre for Respiratory Pathogens, Department of Laboratory Medicine, University Hospitals Leuven, 3000 Leuven, Belgium.
  • Laenen L; National Reference Centre for Respiratory Pathogens, Department of Laboratory Medicine, University Hospitals Leuven, 3000 Leuven, Belgium.
  • Dewaele K; National Reference Centre for Respiratory Pathogens, Department of Laboratory Medicine, University Hospitals Leuven, 3000 Leuven, Belgium.
  • Janssen R; National Reference Centre for Respiratory Pathogens, Department of Laboratory Medicine, University Hospitals Leuven, 3000 Leuven, Belgium.
  • Capron A; Epidemiology of Infectious Diseases and Quality Service Unit, Scientific Directorate of Epidemiology and Public Health, Sciensano, 1000 Brussels, Belgium.
  • Lafort Y; Epidemiology of Infectious Diseases and Quality Service Unit, Scientific Directorate of Epidemiology and Public Health, Sciensano, 1000 Brussels, Belgium.
  • Paridaens H; Clinical Laboratory, Centre Hospitalier Régional de la Citadelle, 4000 Liège, Belgium.
  • Bearzatto B; Federal Testing Platform COVID-19, Centre des Technologies Moléculaires Appliquées (CTMA), Institute of Experimental and Clinical Research (IREC), Cliniques Universitaires Saint-Luc and Université Catholique de Louvain (UCLouvain), 1200 Brussels, Belgium.
  • Cauchie M; Europe Hospitals, 1180 Brussels, Belgium.
  • Huwart A; Clinique André Renard, 4040 Herstal, Belgium.
  • Degosserie J; Federal Testing Platform COVID-19, Department of Laboratory Medicine, CHU UCL Namur, 5530 Yvoir, Belgium.
  • Fagnart O; Saint-Jean Hospital Laboratory, Cebiodi, 1000 Brussels, Belgium.
  • Overmeire Y; Microbiology, Labo Nuytinck, Anacura, 9940 Evergem, Belgium.
  • Rouffiange A; Microbiology, Laboratory Luc Olivier, 5380 Fernelmont, Belgium.
  • Vandecandelaere I; Microbiology, Medisch Labo Bruyland, 8500 Kortrijk, Belgium.
  • Deffontaine M; Laboratory of Clinical Biology, Centre Hopsitalier de Mouscron, 7700 Mouscron, Belgium.
  • Pilate T; Clinical Laboratory, Laboratory Medicine, AZ Diest, 3290 Diest, Belgium.
  • Yin N; Department of Microbiology, Laboratoire Hospitalier Universitaire de Bruxelles-Universitair Laboratorium Brussel (LHUB-ULB), Université de Bruxelles (ULB), 1000 Brussels, Belgium.
  • Micalessi I; Clinical Reference Laboratory, Department of Clinical Sciences, Institute of Tropical Medicine, 2000 Antwerp, Belgium.
  • Roisin S; Microbiology, Centre Hospitalier Universitaire de Tivoli, 7100 La Louvière, Belgium.
  • Moons V; Microbiology, LKO-LMC Medical Laboratory, 3800 Sint-Truiden, Belgium.
  • Reynders M; Laboratory Medicine, AZ Sint-Jan Brugge-Oostende AV, 8000 Brugge, Belgium.
  • Steyaert S; Clinical Laboratory, AZ Maria Middelares, 9000 Gent, Belgium.
  • Henin C; Federal Testing Platform COVID-19, Université Libre de Bruxelles, 1070 Brussels, Belgium.
  • Lazarova E; Centre Hospitalier Régional de la Haute Senne, Department of Clinical Biology, 7060 Soignies, Belgium.
  • Obbels D; Imelda, Clinical Laboratory, 2820 Bonheiden, Belgium.
  • Dufrasne FE; Federal Testing Platform COVID-19, University of Mons, 7000 Mons, Belgium.
  • Pirenne H; Synlab Belgium, Synlab Laboratory Collard, 4020 Liège, Belgium.
  • Schepers R; Synlab Belgium, Synlab Laboratory Heppignies, 6220 Heppignies, Belgium.
  • Collin A; Vivalia, Site Marche-en-Famenne, 6900 Marche, Belgium.
  • Verhasselt B; Federal Testing Platform COVID-19, Department of Laboratory Medicine, Ghent University and Ghent University Hospital, 9000 Gent, Belgium.
  • Gillet L; Federal Testing Platform COVID-19, University of Liège, 4000 Liège, Belgium.
  • Jonckheere S; Jan Yperman Hospital, Laboratory of Clinical Biology, 8900 Ieper, Belgium.
  • Van Lint P; GZA Hospitals, Clinical Laboratory, 2610 Wilrijk, Belgium.
  • Van den Poel B; Clinical Laboratory, General Hospital Jan Portaels, 1800 Vilvoorde, Belgium.
  • Van der Beken Y; Military Medicine Lab Capacity, Military Hospital Queen Astrid, 1120 Brussels, Belgium.
  • Stojkovic V; Centre Hospitalier Bois de l'Abbaye, Laboratory Service, 4100 Seraing, Belgium.
  • Garrino MG; Clinical Laboratory, Site Meuse, CHRSM, 5000 Namur, Belgium.
  • Segers H; AZ Glorieux, Clinical Biology, 9600 Ronse, Belgium.
  • Vos K; RZ Heilig Hart Tienen, Clinical Biology, 3300 Tienen, Belgium.
  • Godefroid M; Labo Maenhout, 8790 Waregem, Belgium.
  • Pede V; AZ Sint-Elisabeth Zottegem, Laboratory of Clinical Biology, 9600 Zottegem, Belgium.
  • Nollet F; Biogazelle NV, Diagnostic Testing, 9052 Zwijnaarde, Belgium.
  • Claes V; Institute of Clinical Biology ULB-IBC, 1170 Brussels, Belgium.
  • Verschraegen I; AZ St-Blasius Dendermonde, 9200 Dendermonde, Belgium.
  • Bogaerts P; CHU UCL Namur, Department of Laboratory Medicine, Molecular Diagnostics Center, 5530 Yvoir, Belgium.
  • Van Gysel M; General Hospital Sint-Maria Halle, 1500 Halle, Belgium.
  • Leurs J; Practimed, 3980 Tessenderlo, Belgium.
Viruses ; 14(6)2022 06 14.
Article in English | MEDLINE | ID: covidwho-1911630
ABSTRACT
From early 2020, a high demand for SARS-CoV-2 tests was driven by several testing indications, including asymptomatic cases, resulting in the massive roll-out of PCR assays to combat the pandemic. Considering the dynamic of viral shedding during the course of infection, the demand to report cycle threshold (Ct) values rapidly emerged. As Ct values can be affected by a number of factors, we considered that harmonization of semi-quantitative PCR results across laboratories would avoid potential divergent interpretations, particularly in the absence of clinical or serological information. A proposal to harmonize reporting of test results was drafted by the National Reference Centre (NRC) UZ/KU Leuven, distinguishing four categories of positivity based on RNA copies/mL. Pre-quantified control material was shipped to 124 laboratories with instructions to setup a standard curve to define thresholds per assay. For each assay, the mean Ct value and corresponding standard deviation was calculated per target gene, for the three concentrations (107, 105 and 103 copies/mL) that determine the classification. The results of 17 assays are summarized. This harmonization effort allowed to ensure that all Belgian laboratories would report positive PCR results in the same semi-quantitative manner to clinicians and to the national database which feeds contact tracing interventions.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: SARS-CoV-2 / COVID-19 Type of study: Diagnostic study / Observational study / Prognostic study Limits: Humans Country/Region as subject: Europa Language: English Year: 2022 Document Type: Article Affiliation country: V14061294

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: SARS-CoV-2 / COVID-19 Type of study: Diagnostic study / Observational study / Prognostic study Limits: Humans Country/Region as subject: Europa Language: English Year: 2022 Document Type: Article Affiliation country: V14061294